Drugs boost Italian health regions' overspend

9 July 2001

The Italian health service regions have estimated that the deficit onspending for 2000 and 2001 is some 16,000 billion lire ($7 million).

The main sources of the current high spending levels are reportedly pharmaceuticals and medical and other salaries. A report on Italy just published by the Organization for Economic Cooperation and Development shows that the country has the highest number of doctors in Europe, at six per 1,000 of population.

The health care bill is estimated to be rising 6%-7% annually, and the signs are that total regional spending in 2002 is unlikely to be less than 150,000 billion lire.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight